Disclosure of the means to produce these vaccines is the quid pro quo for the right to exclude, so waiving the rights is not right in my opinion.
Now, requiring patent holders to license based on a Reasonable and non-discriminatory basis (RAND), or to do something to encourage patent pooling amongst those inventing and producing the vaccines I could support under these circumstances.
For those of you interested in the legal and policy implications, you can read the article at the link
Link: https://opencommons.uconn.edu/cgi/viewcontent.cgi?article=1405&context=law_papers
This message has been edited 1 time(s).